Malignant Solid Tumor
Showing 9951 - 9975 of >10,000
Bladder Cancer, Non-muscle Invasive Trial in Biel (Epirubicin, Mitomycin, Gemcitabine)
Recruiting
- Bladder Cancer
- Non-muscle Invasive
- Epirubicin
- +3 more
-
Biel, SwitzerlandRoland Seiler
Nov 17, 2022
Changing Trends in HCC Procedures
Unknown status
- Hepatocellular Carcinoma
-
Montpellier, FranceUhmontpellier
Mar 9, 2020
NSCLC Trial in Worldwide (Radiotherapy)
Active, not recruiting
- NSCLC
- Radiotherapy
-
Leuven, Belgium
- +6 more
Jan 20, 2022
Complications of Endovascular Methods in Malignant Liver Tumors
Recruiting
- Hepatic Cancer
- +2 more
- Chemoembolization
- Chemoinfusion
-
Moscow, Moscow's Oblast, Russian FederationCentral Clinical Hospital RZD-Medicine, Russian Federation
Feb 17, 2021
Pharmacokinetic Trial in Uppsala (Formulation A GS-248, Formulation B GS-248)
Completed
- Pharmacokinetic
- Formulation A GS-248
- Formulation B GS-248
-
Uppsala, SwedenClinical Trial Consultants AB
Aug 4, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Scottsdale, Jacksonville, Rochester (drug, other, biological)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Acalabrutinib
- +4 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- Proton Beam Radiation Therapy
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2023
Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw
Recruiting
- Advanced Ovarian Carcinoma
- +7 more
-
Bydgoszcz, Kujawsko-pomorskie, Poland
- +2 more
Mar 7, 2023
Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate
Not yet recruiting
- Cancer of Cervix
- Apoptosis
- Immunohistochemistry
- (no location specified)
Nov 17, 2023
Melanoma Trial in United States (Tavokinogene Telseplasmid (tavo), OncoSec Medical System (OMS))
Completed
- Melanoma
- Tavokinogene Telseplasmid (tavo)
- OncoSec Medical System (OMS)
-
San Francisco, California
- +5 more
Oct 1, 2019
Colorectal Cancer Metastatic Trial in Guangzhou (Fruquintinib)
Recruiting
- Colorectal Cancer Metastatic
-
Guangzhou, Guangdong, ChinaColorectal Department,SunYat-sen University Cancer Center
Aug 28, 2023
Solid Carcinoma Trial in Seoul (fecal microbiota transplantation)
Recruiting
- Solid Carcinoma
- fecal microbiota transplantation
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 13, 2020
Jaundice; Malignant Trial in Russian Federation (Remaxol®, Ringer's Solution)
Completed
- Jaundice; Malignant
- Remaxol®
- Ringer's Solution
-
Bryansk, Russian Federation
- +17 more
Jul 9, 2020
Metastatic Ovarian Cancer, Metastatic Fallopian Tube Cancer, Peritoneal Cancer Trial in Herlev (Ipilimumab, Cyclophosphamid,
Recruiting
- Metastatic Ovarian Cancer
- +2 more
- Ipilimumab
- +5 more
-
Herlev, DenmarkNational Center for Cancer Immune Therapy (CCIT-DK)
May 7, 2021
Multiple Myeloma Trial in New York (drug, biological, procedure)
Active, not recruiting
- Multiple Myeloma
- busulfan
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2023
Breast Cancer, Radiation Toxicity Trial in Ghent (Radiotherapy)
Completed
- Breast Cancer
- Radiation Toxicity
- Radiotherapy
-
Ghent, Oost-Vlaanderen, Belgium
- +1 more
Jan 3, 2023
Brain Metastases, Brain Cancer Trial in Miami (18F-Fluciclovine)
Not yet recruiting
- Brain Metastases
- Brain Cancer
-
Miami, FloridaMiami Cancer Institute at Baptist Health South Florida
Jan 3, 2023
Non Small Cell Lung Cancer Trial in Philadelphia (Nivolumab, Ramucirumab)
Recruiting
- Non Small Cell Lung Cancer
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 6, 2022
Orthotopic Neobladders Trial in Assiut (modified Studer ileal neobladder)
Not yet recruiting
- Orthotopic Neobladders
- modified Studer ileal neobladder
-
Assiut, Assuit, EgyptAssuit university
Jan 4, 2023
NSCLC, Metastatic Colorectal Carcinoma, Refractory Melanoma Trial in Pittsburgh (Pixatimod, Nivolumab, Cyclophosphamide (low
Recruiting
- NSCLC
- +2 more
- Pixatimod
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 28, 2022
Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Tazemetostat, Pembrolizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Postgastrectomy Syndrome Trial in Islamabad (active release group, active control group)
Not yet recruiting
- Postgastrectomy Syndrome
- active release group
- active control group
-
Islamabad, Capital, PakistanFederal Breast Cancer Screening center (PIMS)
Aug 10, 2022